Skip to main content

Sexually Transmitted Diseases in Adolescence

  • Chapter
  • First Online:
Good Practice in Pediatric and Adolescent Gynecology

Abstract

The term “Sexually transmitted diseases” (STDs) refers to a variety of clinical syndromes and infections that involve a great number of people all over the world and are caused by pathogens that can be acquired and transmitted through sexual activity. Symptoms related to the infection usually involve the genitalia and urinary tracts, but there are some conditions that may have systemic manifestations. The possibility of contracting an STD in young women is particularly high both due to the biological risks of the age group and due to the behaviour of adolescents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BV:

Bacterial vaginosis

DES:

Diethylstilbestrol

CDC:

Centers for Disease Control and Prevention

CIN:

Cervical intraepithelial neoplasia

ELISA:

Enzyme-linked immunosorbent assay

FTA-ABS:

Fluorescent antibody absorbed treponemal

HBV:

Hepatitis B virus

HCV:

Hepatitis C virus

HIV:

Human immunodeficiency virus

HPV:

Human papillomavirus

HSV:

Herpes simplex virus

LGV:

Lymphogranuloma venereum

MSM:

Men who have sex with men

NAAT:

Nucleic acid amplification test

RPR:

Rapid plasma reagin

SIL:

Squamous intraepithelial lesion

STD:

Sexually transmitted disease

STI:

Sexually transmitted infection

TP-PA:

T. pallidum particle agglutination

VDRL:

Venereal Disease Research Laboratory

VIN:

Vulvar intraepithelial neoplasia

WHO:

World Health Organization

References

  1. World Health Organization. Global Advisory Committee on Vaccine Safety, 11–12 December 2013. Wkly Epidemiol Rec. 2014;89:53–60.

    Google Scholar 

  2. Salfa M C, Regine V, Ferri M et al. La Sorveglianza delle malattie sessualmente trasmesse basata su una rete di centri clinici compie 21 anni (1991-2011) Not. 2013. ISS Volume 26(Numero 6). ISSN 0394-9303.

    Google Scholar 

  3. Workowski KA, Bolan GA. Sexually Transmitted Diseases Treatment Guidelines, 2015.

    Google Scholar 

  4. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections. WHO Library Cataloguing-in-Publication Data. WHO; 2012.

    Google Scholar 

  5. Dake JA, Price JH, Ward BL, Welch PJ. Midwestern rural adolescents’ oral sex experience. J Sch Health. 2011;81(3):159–65.

    Article  PubMed  Google Scholar 

  6. CDC. Sexually transmitted disease surveillance 2013. Atlanta: US Department of Health and Human Services; 2014.

    Google Scholar 

  7. Hafner LM. Pathogenesis of fallopian tube damage caused by clamidia trachomatis infection. Contraception. 2015;92(2):108–15.

    Article  CAS  PubMed  Google Scholar 

  8. Vriend HJ, Bogaards JA, van Bergen JE, Brink AA, van den Broek IV, Hoebe CJ, King AJ, van der Sande MA, Wolffs PF, de Melker HE. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection, 2015.

    Google Scholar 

  9. Zhu H, Shen Z, Luo H, Zhang W, Zhu X. Rewiew Chlamidiatrachomatis infection-associated risk of cervical cancer: a meta-analisis. Medicine (Baltimora). 2016;95(13):e3077.

    Article  Google Scholar 

  10. Papp JR, Schachter J, Gaydos C, et al. Recommendations for the laboratory-based detection of Chlamidia Trachomatis and Neisseria Gonorrheoeae—2014. MMWR Recomm Rep. 2014;63(No. RR-02).

    Google Scholar 

  11. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005;142(11):914–25.

    Article  PubMed  Google Scholar 

  12. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29(9):497–502.

    Article  CAS  PubMed  Google Scholar 

  13. Le Fevre M. Screening for Chlamydia and Gonorrhea: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;161(12):902–10.

    Article  Google Scholar 

  14. LeFevre ML. USPSTF: behavioral counseling interventions to prevent sexually transmitted infections. Ann Intern Med. 2014;161:894–901.

    Article  PubMed  Google Scholar 

  15. De Vries HJC. 2013 European guideline on the management of lymphogranuloma venereum. Switzerland: European Academy of Dermatology and Venereology; 2014.

    Google Scholar 

  16. Vall-Mayans M, Caballero E. Limphogranuloma venereum: an emerging cause of proctitis in Homosexual men in Barcelona. Rev Clin Esp. 2009;209(2):78–81.

    Article  CAS  PubMed  Google Scholar 

  17. Vall-Mayans M, Caballero E, Sanz B. The emergence of lymphogranuloma venereum in Europe. Lancet. 2009;374:356.

    Article  PubMed  Google Scholar 

  18. Gomes JP, Nunes A, Florindo C, Ferreira MA, Santo I, Azevedo J, Borrego MJ. Lymphogranuloma venereum in Portugal: unusual events and new variants during 2007. Sex Transm Dis. 2009;36:88–91.

    Article  PubMed  Google Scholar 

  19. Ceovic R, Jercovic GS. Limphogranuloma venereum: diagnostic and treatment challenges. Infect Drug Resist. 2015;8:39–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lewis DA, Mitjà O. Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen. Curr Opin Infect Dis. 2016;29(1):52–7.

    Article  PubMed  Google Scholar 

  21. Kemp M, Christensen JJ, Lautenschlager S, Vall-Mayans M, Moi H. European guideline for the management of chancroid. Int J STD AIDS. 2011.

    Google Scholar 

  22. Markos AR. Testing asymptomatic heterosexual men for gonorrhoea. Int J STD AIDS. 2010.

    Google Scholar 

  23. Centre for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Atlanta: CDC; 2015.

    Google Scholar 

  24. Barbee LA. Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis. 2014;27(3):282–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148(8):606–13.

    Article  PubMed  Google Scholar 

  26. Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med. 2008;121(10):903–8.

    Article  CAS  PubMed  Google Scholar 

  27. Kumar N, Behera B, Sagiri SS, Pal K, Ray SS, Roy S. Bacterial vaginosis: etiology and modalities of treatment-a brief note. J Pharm Bioallied Sci. 2011;3(4):496–503.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Bernstein DI, Bellamy AR, Hook EW III, Levin MJ, Wald A, Ewell MG, Wolff PA, Deal CD, Heineman TC, Dubin G, Belshe RB. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344–51.

    Article  CAS  PubMed  Google Scholar 

  29. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17–27.

    Article  PubMed  Google Scholar 

  30. Trottier H, Franco EL. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care. 2006;12(17 Suppl):S462–72.

    PubMed  Google Scholar 

  31. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of Human papilloma viruses (HPV), genital warts and cervical cancer. J Infect. 2013;66(3):207–17.

    Article  PubMed  Google Scholar 

  32. World Health Organization. Immunization, vaccines and biologicals human papilloma virus (HPV); 2016.

    Google Scholar 

  33. Henrique LQ, Campaner AB, d’Avila FS. Cervical cancer screening of adolescent should not be encouraged. J Low Genit Tract Dis. 2017;21(1):21–5.

    Article  PubMed  Google Scholar 

  34. Moscicki AB. CHAPTER 11: humanpapilloma virus disease and vaccines in adolescenentes. Adolescent Med State ART Rev. 2010;21(2):347-xi.

    Google Scholar 

  35. American College of Obstetricians and Gynecologists (ACOG). Screening for cervical cancer. ACOG Practice Bulletin Number 131. Obstet Gynecol. 2012;120:1222–38.

    Google Scholar 

  36. Liverani CA, Motta T, Monti E, Puglia D, Mangano S, Bolis G. La Colposcopia in Italia. Anno XXIV-N3-Dicembre 2012. p 22–4.

    Google Scholar 

  37. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147–72.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lu B, Kumar A, Castellsagué X, Giuliano AR. efficacy and safety of prophylactic vaccines against cervical hpv infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Grimaldi-Bensouda L, Rossignol M, Koné-Paut I, Krivitzky A, Lebrun-Frenay C, Clet J, Brassat D, Papeix C, Nicolino M, Benhamou PY, Fain O, Costedoat-Chalumeau N, Courcoux MF, Viallard JF, Godeau B, Papo T, Vermersch P, Bourgault-Villada I, Breart G, Abenhaim L. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance. J Autoimmun. 2017. pii: S0896-8411(16)30214-1.

    Google Scholar 

  40. Drolet M, Bernard E, Boily MC, et al. Populetion-level impact and herd effects following human papillomavirus vaccination programmes: a sistematic review and meta-analysis. Lancet Infect Dis. 2015;15:565–80.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Markowitz LE, Dunne EF, Saraiya M, et al. Human papilloma virus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(No. RR-05).

    Google Scholar 

  42. The American Cancer Society. Guidelines for the prevention and early detection of cervical cancer. 2016.

    Google Scholar 

  43. Baud D, et al. Zika virus: a new threat to human reproduction. Am J Reprod immunol. 2017.

    Google Scholar 

  44. Nicastri E, Castilletti C, Liuzzi G, Iannetta M, Capobianchi MR, Ippolito G. Persistent detection of Zika virus RNA in semen for 6 months after simptom ouset in a traveller returning from Haiti to Italy. Euro Surveill. 2016:21(32).

    Google Scholar 

  45. World Health Organization. Prevention of sexual transmission of Zika virus; 6 Sept 2016.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gilda Di Paolo M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Di Paolo, G. (2018). Sexually Transmitted Diseases in Adolescence. In: Fulghesu, A. (eds) Good Practice in Pediatric and Adolescent Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-57162-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-57162-1_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-57161-4

  • Online ISBN: 978-3-319-57162-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics